- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-162/20 R: Order of the President of the General Court of 12 August 2020 — Indofil Industries (Netherlands) v EFSA (Interim relief — Plant protection products — Regulation (EC) No 1107/2009 — Publication of the conclusion on the review conducted by EFSA regarding the reconsideration of the approval of the active substance mancozeb — Request for certain passages to be treated as confidential — Refusal to grant confidential treatment — Application for interim measures — No prima facie case)
ECLI:EU:UNKNOWN:62020TB0162
62020TB0162
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
3.11.2020
Official Journal of the European Union
C 371/15
(Case T-162/20 R)
(Interim relief - Plant protection products - Regulation (EC) No 1107/2009 - Publication of the conclusion on the review conducted by EFSA regarding the reconsideration of the approval of the active substance mancozeb - Request for certain passages to be treated as confidential - Refusal to grant confidential treatment - Application for interim measures - No prima facie case)
(2020/C 371/17)
Language of the case: English
Parties
Applicant: Indofil Industries (Netherlands) BV (Amsterdam, Netherlands) (represented by: C. Mereu and S. Englebert, lawyers)
Defendant: European Food Safety Authority (EFSA) (represented by: D. Detken and S. Gabbi, acting as Agents, and by G. Rusconi and O. Cesana, lawyers)
Re:
Application pursuant to Articles 278 and 279 TFEU seeking the suspension of the operation of EFSA Decision EFSA/LA/DEC/22911258/2020 of 28 January 2020 concerning the request for internal review of the decision relating to the applicant’s requests for confidential treatment of the conclusion on the peer review of the risk assessment of the active substance mancozeb.
Operative part of the order
1.The application for interim relief is dismissed.
2.The order of 7 April 2020 made in Case T-162/20 R is cancelled.
3.The costs are reserved.